DOCSLIB.ORG

Hormones Steroids Antibodies

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hormones Steroids Antibodies Fitzgerald Industries International is the premier provider of over 45,000 highly purified Monoclonal and Polyclonal Antibodies, purified Proteins, ELISA Kits and Specialty Research Products. For more than 20 years our customers have known that they can depend on Fitzgerald Industries to supply them with high quality products for research and further manufacture. Hormones and their receptors play a central role in the regulation of gene expression. These soluble receptors, when bound to their corresponding hormone, regulate gene expression through direct interaction with promoter response elements. Fitzgerald Industries offers a wide selection of tools that can be used to investigate the function of hormones and their receptors, and our current brochure encompasses over 800 antibodies and purified hormones and steroids spanning a vast range of targets including steroid hormones such as Glucocorticoids, Estrogens, Androgens; small peptide hormones such as TRH and vasopressin; protein hormones such as insulin and growth hormones; and glycoprotein hormones such as LH, TSH, and FSH. In addition, we offer comprehensive listings in other research areas including Cancer, Cell Biology, Immunology, Infectious Disease, Signal Transduction, Neuroscience, Cytokines & Growth Factors, Cardiac Markers, Protein Modification, Cell Death & Stress, and many more. Visit our website at www.fitzgerald-fii.com to view our complete offerings and full technical data. www.fitzgerald-fii.com/Hormones & Steroids Hormones & Steroids 1 Fitzgerald Industries International HeaderMonoclonal Antibodies Catalog No. Product Name Host Clone Size 10C-CR1045M1 17 beta Estradiol antibody Mouse 53114 1 mg 10R-3148 ACD antibody Mouse 1C8 100 ul 10R-6784 ACD antibody Mouse 1A2 100 ul 10-A31A ACTH antibody Mouse M31241 1 mg 10-A31A ACTH antibody Mouse M31241 100 ug 10-A32A ACTH antibody Mouse M31263 1 mg 10C-CR1096M1 ACTH antibody Mouse 363121 100 ug 10C-CR1096M2 ACTH antibody Mouse 753600 100 ug 10R-A125a Amylin antibody Mouse R10/99 1 ml 10R-A129a Androgen Receptor antibody Mouse AR 441 200 ug 10R-A129a Androgen Receptor antibody Mouse AR 441 100 ug 10R-2328 AR antibody Mouse F39.4 1 ml 10R-2114 BNP antibody Mouse 8D5B4C11 100 ul 10R-2115 BNP antibody Mouse 9H6B4,9H6H4A7 100 ul 10R-2116 BNP antibody Mouse 3A6F7C7 100 ul 10-G06A Bovine Growth Hormone antibody Mouse M510257 1 mg 10-C65B C Peptide antibody Mouse M8120921 1 mg 10-C65C C Peptide antibody Mouse M8120922 1 mg 10R-6732 C Peptide antibody Mouse HCP-B2 100 ug 10-C65A C Peptide antibody Mouse M607239 1 mg 10R-3561 C2orf40 antibody Mouse 3B10 100 ul 10R-3562 C2orf40 antibody Mouse 1A10 100 ul 10R-3563 C2orf40 antibody Mouse 1F6 100 ul 10-C08A Calcitonin antibody Mouse M904291 200 ug 10-C08B Calcitonin antibody Mouse M904292 200 ug 10-C08C Calcitonin antibody Mouse M904293 200 ug 10-7891 Calcitonin antibody Mouse M18612CT1 500 ug 10-7892 Calcitonin antibody Mouse M18612CT2 500 ug 10R-2291 CgA antibody Mouse LK2H10 1 ml 10R-C126a Chromogranin A antibody Mouse LK2H10 100 ug 10R-C126ax Chromogranin A antibody Mouse PHE5 200 ug 10R-C127a Chromogranin A antibody Mouse PHE5 100 ug 10R-C128a Chromogranin A antibody Mouse LK2H10 & PHE5 200 ug 10R-C125a Chromogranin A antibody Rabbit SP12 500 ul 10R-6770 Chromogranin A antibody Mouse LK2H10 500 ul 10R-6770 Chromogranin A antibody Mouse LK2H10 1 ml 10R-7450 Chromogranin A antibody Mouse 23A1 100 ug 10R-C143a Corticoliberin antibody Mouse 5D5 1 mg 10-C30B Cortisol 3 antibody Mouse M49128 1 mg 10C-CR2107M2 Cortisol 3 antibody Mouse 2127485 1 mg 10-C30D Cortisol antibody Mouse M021509 1 mg 10R-C145a Cortisol antibody Mouse XM210 1 mg 10R-E115b EPO antibody Mouse Epo1 1 mg www.fitzgerald-fii.com/Hormones & Steroids T 978.371.6446 • F 978.371.2266 • Email: [email protected] 2 Hormones & Steroids Fitzgerald Industries International Monoclonal AntibodiesHeader Catalog No. Product Name Host Clone Size 10R-E115a EPO antibody Mouse Epo2 1 mg 10C-CR1196M2 EPO antibody Mouse 813600 100 ug 10C-CR1196M1 EPO antibody Mouse 5710200 100 ug 10R-2778 EPO antibody Mouse 4F11 100 ul 10R-7779 EPO antibody Mouse Epo2 150 ug 10R-7781 EPO antibody Mouse NYRhEPO 500 ug 61R-E115bBT EPO antibody (biotin) Mouse Epo1 1 mg 61R-E115bHRP EPO antibody (HRP) Mouse Epo1 1 mg 10-7901 Erythropoetin antibody Mouse M18612EP1 1 mg 10-7902 Erythropoetin antibody Mouse M18612EP2 1 mg 10-E115b Erythropoetin antibody Mouse M12619EP1 1 mg 10-E115a Erythropoetin antibody Mouse M12619EP2 1 mg 10R-E122a Estradiol 17b antibody Mouse ESTR-1 1 mg 10-E14A Estradiol 6 antibody Mouse M40557 1 mg 10-E15A Estradiol 6 antibody Mouse M405233 1 mg 10-E15B Estradiol 6,17b antibody Mouse M94150 1 mg 10-E37E Estriol 3 antibody Mouse M612039 1 mg 10-E37C Estriol 3 antibody Mouse M612035 1 mg 10-E37D Estriol 3 antibody Mouse M612034 1 mg 10-E37B Estriol 3 antibody Mouse M612033 1 mg 10-E37A Estriol 3 antibody Mouse M612030 1 mg 10R-E117a Estrogen Receptor antibody Mouse AER314 100 ug 10R-E118a Estrogen Receptor antibody Mouse TE111.5D11 100 ug 10R-E124a Estrogen Receptor antibody Rat H222 200 ug 10R-E124a Estrogen Receptor antibody Rat H222 100 ug 10R-2329 Estrogen Receptor antibody Mouse 6F11 1 ml 10-F20A FSH alpha antibody Mouse M94136 1 mg 10-F15A FSH antibody Mouse M210201 1 mg 10C-CR2109M3 FSH antibody Mouse 2127475 1 mg 10C-CR2109M4 FSH antibody Mouse 227475 1 mg 10C-CR2109M2 FSH antibody Mouse 4611820 1 mg 10-F15B FSH antibody Mouse M27301 1 mg 10-F15D FSH antibody Mouse M607109 1 mg 10-F15C FSH antibody Mouse M94166 1 mg 10R-2320 FSH antibody Mouse 1038 1 ml 10-7978 FSH antibody Mouse M18612FSH1 1 mg 10-7979 FSH antibody Mouse M18612FSH2 1 mg 61R-F119bHRP FSH antibody (HRP) Mouse FSH182 1 mg 61-F26B FSH antibody (HRP) Mouse M607109-HRP 500 ug 10R-F119a FSH beta antibody Mouse FSH909 1 mg 10-F25A FSH beta antibody Mouse M94167 1 mg 10-F25B FSH beta antibody Mouse M606241 1 mg T 978.371.6446 • F 978.371.2266 • Email: [email protected] www.fitzgerald-fii.com/Hormones & Steroids Hormones & Steroids 3 Fitzgerald Industries International Monoclonal Antibodies Catalog No. Product Name Host Clone Size 10-F25C FSH beta antibody Mouse M94170 1 mg 10R-7518 FSH beta antibody Mouse 7D10 1 mg 61-F26A FSH beta antibody (HRP) Mouse M605113-HRP 500 ug 10R-4146 FSHB antibody Mouse 4 E10 100 ul 10R-4147 FSHB antibody Mouse 4 E8 100 ul 10R-4148 FSHB antibody Mouse 1B2 100 ul 10R-4149 FSHB antibody Mouse 3A9 100 ul 10R-4150 FSHB antibody Mouse 2 E5 100 ul 10R-4151 FSHB antibody Mouse 4B9 100 ul 10R-4152 FSHB antibody Mouse 4D12 100 ul 10R-4153 FSHB antibody Mouse 2A6 100 ul 10R-4154 FSHB antibody Mouse 2G9 100 ul 10-7910 GCSF antibody Mouse M18612GC1 500 ug 10-7911 GCSF antibody Mouse M18612GC2 500 ug 10-7912 GCSF antibody Mouse M18612GC3 500 ug 10-7913 GCSF antibody Mouse M18612GC4 500 ug 10R-7801 GH antibody Mouse PG3H5AT 50 ug 10R-1934 GLP1 antibody Mouse 1B7B4 100 ug 10R-G113a GnRHR antibody Mouse A9E4 1 ml 10-G43A GnRHR antibody Mouse M0201127 1 mg 10-G43B GnRHR antibody Mouse M0201128 1 mg 10R-1006 Growth Hormone antibody Mouse g3H5 100 ul 10R-7291 Growth hormone antibody Mouse GH-15 100 ug 10-C20B hCG alpha antibody Mouse M7051921 1 mg 10-C20A hCG alpha antibody Mouse M94136 1 mg 10R-L106a hCG alpha antibody Mouse FSH410 1 mg 10C-CR2108M3 hCG alpha antibody Mouse M1206HCG 1 mg 10R-7514 hCG alpha antibody Mouse 23E11 1 mg 61-L05A hCG alpha antibody (HRP) Mouse M94136-HRP 500 ug 61R-L111aHRP hCG alpha antibody (HRP) Mouse 176-HRP 1 mg 10R-7293 hCG beta antibody Mouse HCG-8 100 ug 10-C15A hCG antibody Mouse M94213 1 mg 10R-C175a hCG antibody Mouse 27E8 1 mg 10-3126 hCG antibody Mouse MH-95 1 mg 10-3127 hCG antibody Mouse M1202082 1 mg 10R-6762 hCG antibody Mouse HCG 205 500 ul 10R-6762 hCG antibody Mouse HCG 205 1 ml 10-7980 hCG antibody Mouse M18612HC1 1 mg 10-7981 hCG antibody Mouse M18612HC2 1 mg 61-H10C hCG antibody (HRP) Mouse M94140-HRP 500 ug 10-C25C hCG beta antibody Mouse M705159 1 mg 10-C25G hCG beta antibody Mouse M901021 1 mg www.fitzgerald-fii.com/Hormones & Steroids T 978.371.6446 • F 978.371.2266 • Email: [email protected] 4 Hormones & Steroids Fitzgerald Industries International Monoclonal Antibodies Catalog No. Product Name Host Clone Size 10-C25D hCG beta antibody Mouse M94138 1 mg 10R-C182b hCG beta antibody Mouse 151 1 mg 10R-C182a hCG beta antibody Mouse HCG03 1 mg 10-C25B hCG beta antibody Mouse M94140 1 mg 10C-CR1047M6 hCG beta antibody Mouse M48257 1 mg 10-C25E hCG beta antibody Mouse M94139.7 1 mg 10-C25A hCG beta antibody Mouse M48257 1 mg 10-C25FS hCG beta antibody Mouse M15294 1 mg 10-C25H hCG beta antibody Mouse M94141 1 mg 10R-7515 hCG beta antibody Mouse 8F7 1 mg 10R-7751 hCG beta antibody (core) Mouse NYRhCG 500 ug 61-H10B hCG beta antibody (HRP) Mouse M94138-HRP 500 ug 61R-C182cHRP hCG beta antibody (HRP) Mouse 152 1 mg 61-H10A hCG beta antibody (HRP) Mouse M94139-HRP 500 ug 10R-6985 HSD17B2 antibody Mouse 4F10 100 ul 10R-7782 Human Growth Hormone antibody Mouse NYRhHGH 500 ug 10C-CR2147M3 Human Growth Hormone antibody Mouse 2127495 1 mg 10-G05D Human Growth Hormone antibody Mouse M0410181 1 mg 10-G05C Human Growth Hormone antibody Mouse M0410182 1 mg 10R-2980 Human Growth Hormone antibody Rat KT19 100 ug 10-G119b Human Growth Hormone antibody Mouse M12619GH1 1 mg 10-G119a Human Growth Hormone antibody Mouse M12619GH2 1 mg 10R-G119c Human Growth Hormone antibody Mouse Gh29 1 mg 10R-G119b Human Growth Hormone antibody Mouse GhB9 1 mg 10R-G119a Human Growth Hormone antibody Mouse GhG2 1 mg 10-G05B Human Growth Hormone antibody Mouse M94169 1 mg 61-G05A Human Growth Hormone
Load more

Recommended publications
  • Therapeutic Approaches to Preserve Islet Mass in Type 2 Diabetes
    24 Dec 2005 16:24 AR ANRV262-ME57-17.tex XMLPublishSM(2004/02/24) P1: OJO 10.1146/annurev.med.57.110104.115624 Annu. Rev. Med. 2006. 57:265–81 doi: 10.1146/annurev.med.57.110104.115624 Copyright c 2006 by Annual Reviews. All rights reserved THERAPEUTIC APPROACHES TO PRESERVE ISLET MASS IN TYPE 2DIABETES Laurie L. Baggio and Daniel J. Drucker Department of Medicine, Toronto General Hospital, Banting and Best Diabetes Center, University of Toronto, Toronto, Ontario, Canada M5S 2S2; email: [email protected] KeyWords β-cell mass, apoptosis, neogenesis, proliferation ■ Abstract Type 2 diabetes is characterized by hyperglycemia resulting from in- sulin resistance in the setting of inadequate β-cell compensation. Currently available therapeutic agents lower blood glucose through multiple mechanisms but do not directly reverse the decline in β-cell mass. Glucagon-like peptide-1 (GLP-1) receptor agonists, exemplified by Exenatide (exendin-4), not only acutely lower blood glucose but also engage signaling pathways in the islet β-cell that lead to stimulation of β-cell repli- cation and inhibition of β-cell apoptosis. Similarly, glucose-dependent insulinotropic polypeptide (GIP) receptor activation stimulates insulin secretion, enhances β-cell proliferation, and reduces apoptosis. Moreover, potentiation of the endogenous post- prandial levels of GLP-1 and GIP via inhibition of dipeptidyl peptidase-IV (DPP-IV) also expands β-cell mass via related mechanisms. The thiazolidinediones (TZDs) en- hance insulin sensitivity, reduce blood glucose levels, and also preserve β-cell mass, although it remains unclear whether TZDs affect β-cell mass via direct mechanisms. Complementary approaches to regeneration of β-cell mass involve combinations of factors, exemplified by epidermal growth factor and gastrin, which promote islet neo- genesis and ameliorate diabetes in rodent studies.
    [Show full text]
  • Strategies to Increase ß-Cell Mass Expansion
    This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Strategies to increase -cell mass expansion Drynda, Robert Lech Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 Strategies to increase β-cell mass expansion A thesis submitted by Robert Drynda For the degree of Doctor of Philosophy from King’s College London Diabetes Research Group Division of Diabetes & Nutritional Sciences Faculty of Life Sciences & Medicine King’s College London 2017 Table of contents Table of contents .................................................................................................
    [Show full text]
  • Redirecting Intracellular Trafficking and the Secretion Pattern of FSH Dramatically Enhances Ovarian Function in Mice
    Redirecting intracellular trafficking and the secretion pattern of FSH dramatically enhances ovarian function in mice Huizhen Wanga, Melissa Larsona, Albina Jablonka-Shariffb, Christopher A. Pearlb, William L. Millerc, P. Michael Connd, Irving Boimeb, and T. Rajendra Kumara,e,1 Departments of aMolecular and Integrative Physiology and ePathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160; bDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110; cDepartment of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695; and dDepartments of Internal Medicine and Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430 Edited by R. Michael Roberts, University of Missouri, Columbia, MO, and approved February 28, 2014 (received for review November 14, 2013) FSH and luteinizing hormone (LH) are secreted constitutively or in Results pulses, respectively, from pituitary gonadotropes in many vertebrates, Strategy to Redirect FSH from the Constitutive to Regulated Pathway. Our and regulate ovarian function. The molecular basis for this evolution- in vitro screens indicated that a carboxyterminal (C′)-heptapeptide arily conserved gonadotropin-specific secretion pattern is not un- in the human LHβ (LSGLLFL) (12) or a modified FSHβ con- derstood. Here, we show that the carboxyterminal heptapeptide in taining this peptide (13) favors secretion of corresponding dimers LH is a gonadotropin-sorting determinant in vivo that directs pulsatile via the regulated pathway in heterologous somatotrope cells. secretion. FSH containing this heptapeptide enters the regulated Based on these initial data, we engineered human transgenes en- pathway in gonadotropes of transgenic mice, and is released in β ′ response to gonadotropin-releasing hormone, similar to LH.
    [Show full text]
  • Dynamic Gnrh and Hcg Testing: Establishment of New Diagnostic Reference Levels
    176:4 PROOF ONLY A K Bang and others Reference levels on GnRH and 176:4 379–391 Clinical Study hCG tests Dynamic GnRH and hCG testing: establishment of new diagnostic reference levels A Kirstine Bang1,2, Loa Nordkap1,2, Kristian Almstrup1,2, Lærke Priskorn1,2, Jørgen Holm Petersen1,2,3, Ewa Rajpert-De Meyts1,2, Anna-Maria Andersson1,2, Anders Juul1,2 and Niels Jørgensen1,2 1Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Correspondence Denmark, 2International Center for Research and Research Training in Endocrine Disruption of Male should be addressed Reproduction and Child Health (EDMaRC), Rigshospitalet, Denmark, and 3Department of Biostatistics, to N Jørgensen University of Copenhagen, Copenhagen, Denmark Email [email protected] Abstract Objective: Gonadotropin-releasing hormone (GnRH) and human chorionic gonadotropin (hCG) stimulation tests may be used to evaluate the pituitary and testicular capacity. Our aim was to evaluate changes in follicular-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone after GnRH and hCG stimulation in healthy men and assess the impact of six single nucleotide polymorphisms on the responses. Design: GnRH and hCG stimulation tests were performed on 77 healthy men, 18–40 years (reference group) at a specialized andrology referral center at a university hospital. The potential influence of the tests was illustrated by results from 45 patients suspected of disordered hypothalamic–pituitary–gonadal axis. Methods: Baseline, stimulated, relative and absolute changes in serum FSH and LH were determined by ultrasensitive TRIFMA, and testosterone was determined by LC–MS/MS. Results: For the reference group, LH and FSH increased almost 400% and 40% during GnRH testing, stimulated levels varied from 4.4 to 58.8 U/L and 0.2 to 11.8 U/L and FSH decreased in nine men.
    [Show full text]
  • Interleukin 6 Inhibits Mouse Placental Lactogen II but Not Mouse Placental Lactogen I Secretion in Vitro (Trophoblast/Pregnancy/Cytokine) M
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 11905-11909, December 1993 Physiology Interleukin 6 inhibits mouse placental lactogen II but not mouse placental lactogen I secretion in vitro (trophoblast/pregnancy/cytokine) M. YAMAGUCHI*t, L. OGREN*, J. N. SOUTHARD*, H. KURACHI*, A. MIYAKEt, AND F. TALAMANTES*§ *Department of Biology, University of California, Santa Cruz, CA 95064; and tDepartment of Obstetrics and Gynecology, Osaka University Medical School, Osaka, Japan 565 Communicated by George E. Seidel, Jr., September 7, 1993 (receivedfor review June 9, 1993) ABSTRACT The mouse placenta produces several poly- members ofthe PRL-GH gene family. We have used primary peptides belonging to the prolactin-growth hormone gene fam- cultures of placental cells from several days of pregnancy to ily, including mouse placental lactogen (mPL) I and mPL-II. demonstrate that IL-6 regulates the secretion of mPL-II, but The present study was undertaken to determine whether the not mPL-I, and that the sensitivity of mPL-II secretion to secretion of mPL-I and mPL-H is regulated by interleukin 6 IL-6 varies during gestation. (IL-6), which is present in the placenta and has previously been reported to stimulate the secretion ofpituitary members of this gene family. Effects of human and mouse IL-6 on mPL-I and MATERIALS AND METHODS mPL-II secretion were examined in primary cultures of pla- Hormones, Cytokines, and Antisera. mPL-II and recombi- cental cells from days 7, 9, and 12 of pregnancy. IL-6 caused nant mPL-I were purified as described (10, 16). Rabbit a dose-dependent reduction in the mPL-HI concentration in the anti-mPL-I and rabbit anti-mPL-II antisera have been de- medium of cells from days 9 and 12 of pregnancy but did not scribed (11, 16).
    [Show full text]
  • Placental Growth Hormone-Related Proteins and Prolactin-Related Proteins
    Placental Growth Hormone-Related Proteins and Prolactin-Related Proteins The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Haig, D. 2008. Placental growth hormone-related proteins and prolactin-related proteins. Placenta 29: 36-41. Published Version doi:10.1016/j.placenta.2007.09.010 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11148777 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Placental growth hormone-related proteins and prolactin-related proteins. David Haig Department of Organismic and Evolutionary Biology, Harvard University, 26 Oxford Street, Cambridge MA 02138. e-mail: [email protected] phone: 617-496-5125 fax: 617-495-5667 Keywords: GH, PRL, placenta, endometrial glands, placental lactogen The placentas of ruminants and muroid rodents express prolactin (PRL)-related genes whereas the placentas of anthropoid primates express growth hormone (GH)-related genes. The evolution of placental expression is associated with acclerated evolution of the corresponding pituitary hormone and destabilization of conserved endocrine systems. In particular, placental hormones often evolve novel interactions with new receptors. The adaptive functions of some placental hormones may be revealed only under conditions of physiological stress. Introduction Placental hormones are produced by offspring, but act on receptors of mothers. As such, placental hormones and maternal receptors are prime candidates for the expression of parent-offspring conflict [1,2].
    [Show full text]
  • Maternal Adiponectin Prevents Visceral Adiposity and Adipocyte Hypertrophy in Prenatal Androgenized Female Mice
    Received: 25 September 2020 | Revised: 26 November 2020 | Accepted: 7 December 2020 DOI: 10.1096/fj.202002212R RESEARCH ARTICLE Maternal adiponectin prevents visceral adiposity and adipocyte hypertrophy in prenatal androgenized female mice Yanling Wu1 | Belén Chanclón1 | Peter Micallef1 | qElisabet Stener-Victorin2 | Ingrid Wernstedt Asterholm1 | Anna Benrick1,3 1Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Abstract Academy, University of Gothenburg, Hyperandrogenism is the main characteristic of polycystic ovary syndrome, which Gothenburg, Sweden affects placental function and fetal growth, and leads to reproductive and metabolic 2 Department of Physiology and dysfunction in female offspring. Adiponectin acts on the placenta and may exert Pharmacology, Karolinska Institute, Stockholm, Sweden endocrine effects on the developing fetus. This study aims to investigate if mater- 3School of Health Sciences, University of nal and/or fetal adiponectin can prevent metabolic and reproductive dysfunction in Skövde, Skövde, Sweden prenatal androgenized (PNA) female offspring. Adiponectin transgenic (APNtg) and wild-type dams received dihydrotestosterone/vehicle injections between gesta- Correspondence Anna Benrick, Department of Physiology, tional days 16.5-18.5 to induce PNA offspring, which were followed for 4 months. University of Gothenburg, Institute of Offspring from APNtg dams were smaller than offspring from wild-type dams, in- Neuroscience and Physiology, Box 423, 405 30 Gothenburg, Sweden. dependent of genotype. Insulin sensitivity was higher in wild-type mice from APNtg Email: [email protected] dams compared to wild-types from wild-type dams, and insulin sensitivity correlated with fat mass and adipocyte size. PNA increased visceral fat% and adipocyte size in Funding information Novo Nordisk Fonden (NNF), Grant/ wild-type offspring from wild-type dams, while wild-type and APNtg offspring from Award Number: NNF19OC0056601; APNtg dams were protected against this effect.
    [Show full text]
  • Follicle-Stimulating Hormone Regulates Expression and Activity of Epidermal Growth Factor Receptor in the Murine Ovarian Follicle
    Follicle-stimulating hormone regulates expression and activity of epidermal growth factor receptor in the murine ovarian follicle Stephany El-Hayeka,b,c, Isabelle Demeesterea,c,d, and Hugh J. Clarkea,b,c,e,1 Departments of aObstetrics and Gynecology, bBiology, and eMedicine, McGill University, Montreal, QC, Canada H3A 1A1; cResearch Institute–McGill University Health Centre; Montreal, QC, Canada H3A 1A1; and dResearch Laboratory on Human Reproduction Fertility Clinic, Université Libre de Bruxelles Erasme, 1070 Brussels, Belgium Edited by John J. Eppig, The Jackson Laboratory, Bar Harbor, ME, and approved October 21, 2014 (received for review August 4, 2014) Fertility depends on the precise coordination of multiple events view that the EGFR signaling mediates many or most ovulatory within the ovarian follicle to ensure ovulation of a fertilizable egg. events. First, the release of the EGFR ligands follows the LH surge FSH promotes late follicular development, including expression of but precedes the LH-dependent responses (9–11). Second, EGF luteinizing hormone (LH) receptor by the granulosa cells. Expres- and the EGFR ligands can induce cumulus expansion and oocyte sion of its receptor permits the subsequent LH surge to trigger the maturation in vitro, independently of LH (9, 10, 20, 29). Third, release of ligands that activate EGF receptors (EGFR) on the gran- these events are impaired in mice bearing a hypomorphic Egfr allele ulosa, thereby initiating the ovulatory events. Here we identify a previously unknown role for FSH in this signaling cascade. We that reduces EGFR activity by about one-half and in mice in which show that follicles of Fshb−/− mice, which cannot produce FSH, Egfr has been selectively inactivated in GCs through a targeted have a severely impaired ability to support two essential EGFR- mutation (22, 23).
    [Show full text]
  • The Importance of Determining Human
    JMB 2009; 28 (2) DOI: 10.2478/v10011-009-0003-1 UDK 577.1 : 61 ISSN 1452-8258 JMB 28: 97–100, 2009 Original paper Originalni nau~ni rad THE IMPORTANCE OF DETERMINING HUMAN PLACENTAL LACTOGEN IN THE THIRD TRIMESTER OF PREGNANCY ZNA^AJ ODRE\IVANJA HUMANOG PLACENTALNOG LAKTOGENA U TRE]EM TRIMESTRU TRUDNO]E Jasmina Durkovi}1, Bojana Mandi}2 1Department of Genetics , Town Hospital, Subotica, Serbia 2Mega Lab, Biochemical Laboratory, Subotica, Serbia Summary: Human placental lactogen (HPL) is a hormone Kratak sadr`aj: Humani placentalni laktogen (HPL) jeste produced by the placenta with a role in the re gu lation of hormon koji izlu~uje placenta i regulator je fetoplacen- fetoplacental growth. In this paper, the results of HPL de- talnog rasta. U radu su prikazani rezultati odre|ivanja HPL- termination in the third trimester of pregnancy are pre- a u tre}em trimestru trudno}e, sa ciljem da se ispita senzi - sented with the aim of testing the sensitivity of this bio - tivnost tog biohemijskog markera za otkrivanje poreme}aja chemical marker for detecting placental dysfunction, fetal funkcije placente, vitaliteta fetusa i rizika za lo{ ishod. vitality and risk of bad outcome. The tests were performed Ispitivanje je obavljeno na uzorku od 370 rizi~nih trudno}a on 370 women with high-risk pregnancy, between the 20th izme|u 20 i 36 nedelje trudno}e. HPL je odre|en ELISA and 36th week of pregnancy. HPL was determined by an metodom, testovima »Bioserv Diagnostics«, a rezultati su ELISA method using Bioserv Diagnostics tests and the o~itani na rideru »STAT–FAX 303+«.
    [Show full text]
  • An Exploration of Non-Coding RNA in Exosomes Delivered by Swine Anterior Pituitary
    An exploration of non-coding RNA in exosomes delivered by swine anterior pituitary Jiali Xiong South China Agricultural University Haojie Zhang South China Agricultural University Bin Zeng South China Agricultural University Jie Liu South China Agricultural University Junyi Luo South China Agricultural University Ting Chen South China Agricultural University Jiajie Sun South China Agricultural University Qianyun Xi South China Agricultural University Yong-Liang Zhang ( [email protected] ) South China Agricultural University Research article Keywords: Anterior pituitary exosomes, MiRNA, LncRNA, CircRNA, Cross-talk Posted Date: July 29th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-36112/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/26 Abstract Background: The anterior pituitary is a key endocrine organ both in animal and human being drawing much concern. Exosomes are extracellular secretory vesicles carrying proteins, lipids and small RNAs. Previous studies have demonstrated that they had regulatory function both physiologically and pathologically. However, information on exosomes from anterior pituitary remains unknown. Results: In this study, we separated and identied exosomes from anterior pituitary of Duroc swine model for the rst time. Total RNA was extracted and RNA-seq was performed, followed by a comprehensive analysis of miRNAs, lncRNAs and circRNAs. Resultantly, we obtained 343 known miRNAs and 73 novel miRNAs, 15545 lncRNAs and 494 circRNAs. Furthermore, GO and KEGG enrichment analysis showed that the ncRNAs in exosomes may participate in regulating intracellular signal transduction, cellular component organization or biogenesis, small molecule binding, transferase activity. The cross-talk between them also suggested that they may play an important role in signaling process and the biological regulation.
    [Show full text]
  • Single Cell Transcriptomic Analysis of the Adult Mouse Pituitary Reveals a Novel Multi-Hormone Cell Cluster and Physiologic Demand-Induced Lineage Plasticity
    bioRxiv preprint doi: https://doi.org/10.1101/475558; this version posted November 22, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Single cell transcriptomic analysis of the adult mouse pituitary reveals a novel multi-hormone cell cluster and physiologic demand-induced lineage plasticity Yugong Ho1,5,*. Peng Hu1,3,5, Michael T. Peel1, Pablo G. Camara1,4, Hao Wu1,3,* , and Stephen A. Liebhaber1,2, Departments of Genetics1 and Medicine2, Penn Epigenetics Institute3, and Penn Institute for Biomedical Informatics4, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 5 These authors contributed equally * Corresponding authors Running title: Single cell transcriptomic analysis of the adult mouse pituitary 1 bioRxiv preprint doi: https://doi.org/10.1101/475558; this version posted November 22, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The anterior pituitary gland drives a set of highly conserved physiologic processes in mammalian species. These hormonally-controlled processes are central to somatic growth, pubertal transformation, fertility, lactation, and metabolism. Current models, based on targeted immuno-histochemical and mRNA analyses, suggest that each of the seven hormones synthesized by the pituitary is produced by a specific and exclusive cell lineage. However, emerging evidence suggests a more complex model in which critical aspects of hormone specificity and plasticity of pituitary cells remain undefined. Here we have applied massively parallel single-cell RNA sequencing (scRNA-seq), in conjunction with a set of orthogonal imaging studies, to systematically map the cellular composition of adult male and female mouse pituitaries at single-cell resolution and in the setting of major physiologic demands.
    [Show full text]
  • The Endocrine Function of the Placenta: Interactions Between Trophic Peptides and Hormones
    Placenlal Function and Fetal Nutrition, edited by Frederick C. Battaglia, Nestle Nutrition Workshop Series. Vol. 39. Nestec Ltd.. Vevey/Lippincott-Raven Publishers. Philadelphia. © 1997. The Endocrine Function of the Placenta: Interactions Between Trophic Peptides and Hormones Lise Cedard U. 361 INSERM, Maternite Baudelocque, 121 Boulevard de Port-Royal Paris, France The placenta is classically considered to be a source of hormones that play an important role in the establishment and maintenance of pregnancy. Because of its hemochorial structure, the human placenta produces hormones and easily secretes them into the maternal circulation. They include steroid hormones, such as estrogens and progesterone, and protein hormones, the most important of which are the chori- onic gonadotrophins (hCG), discovered in 1927. During the period from 1960 to 1980, the concept of a fetoplacental unit (1) with a complementary role for the fetus in steroid production offered a new approach to steroid metabolism, and since then new proteins and neuropeptides have been discovered (2,3). However, the lack of innervation of placental tissue highlights the importance of understanding neuroen- docrine regulation of placental physiology. Sophisticated culture methods enabling the study of biologic phenomena occurring during transformation of cytotrophoblast cells into a syncytiotrophoblast (4) have been combined with electron microscopy and histochemistry. Possibilities offered by molecular biology, including in situ hybridization and molecular cloning studies,
    [Show full text]